Renal Insufficiency, Chronic: all 3,224 studies

Page 31 of 33. Open to participants first (706), then studies with results posted, then the rest; newest registration first within each.

• Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease SubjectsCompletedNCT00888069Phase 1
• Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental GlomerulosclerosisTerminatedNCT00883636
• Vitamin D, Chronic Kidney Disease (CKD) and the MicrocirculationCompletedNCT00882401Phase 4
• Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)WithdrawnNCT00869856Phase 3
• Kremezin Study Against Renal Disease Progression in KoreaCompletedNCT00860431Phase 4
• The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent ProteinuriaStatus unknownNCT00858299Phase 4
• Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney DiseaseWithdrawnNCT00849316
• Fluid Intake in Kidney FailureCompletedNCT00842322Not applicable
• Vascular Changes Following Forearm Loop Arteriovenous Graft PlacementCompletedNCT00836563
• A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on DialysisTerminatedNCT00833768Phase 3
• Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal FailureCompletedNCT00828776Phase 2/3
• Canadian Study of Prediction of Risk and Evolution to Dialysis, Death and Interim Cardiovascular Events Over TimeStatus unknownNCT00826319
• Heart Rate Variability in Chronic Kidney Disease PatientsStatus unknownNCT00824577
• Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus IopromideCompletedNCT00823628Phase 4
• Renal Function Assessment in HIV PatientCompletedNCT00821847
• Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSeaseCompletedNCT00818792Phase 2
• Sleep Disturbances as a Non-traditional Risk Factor in CKD-ActigraphyCompletedNCT00817674
• Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease- University of IllinoisCompletedNCT00817492
• Sleep Disturbances as a Risk Factor in Chronic Kidney DiseaseCompletedNCT00817427Not applicable
• Sitaxsentan in Proteinuric Chronic Kidney DiseaseCompletedNCT00817037Phase 2
• Calcineurin Free Immunosuppression in Renal Transplant RecipientsCompletedNCT00812123Phase 4
• Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNCT00811889Phase 2
• Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney DiseaseCompletedNCT00808795Phase 3
• Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney DiseaseCompletedNCT00806481Phase 2
• Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy SubjectsCompletedNCT00805090Phase 1
• Chronic Kidney Disease in Pakistani PopulationStatus unknownNCT00800878
• Oral Paricalcitol in Stage 3 - 5 Chronic Kidney DiseaseCompletedNCT00796679Not applicable
• Chemoreflex Sensitivity in Chronic Kidney DiseaseCompletedNCT00794872
• Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney DiseaseCompletedNCT00793806
• Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)CompletedNCT00792857Phase 1
• Reduction of Mortality Prior to and During the First 90 Days of Dialysis Through a Renal Rehabilitation ProgramCompletedNCT00792454Not applicable
• Sensitivity and Specificity of NGAL in an Emergency Room PopulationCompletedNCT00786708
• Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With DiabetesCompletedNCT00786136Phase 4
• A Randomized Trial to Reduce the Disparity in Live Donor Kidney TransplantationCompletedNCT00785265Not applicable
• Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney DiseaseCompletedNCT00781417Not applicable
• Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)CompletedNCT00773409
• Disc Edema in Patients With Chronic Kidney DiseaseWithdrawnNCT00769834
• Study of Atorvastatin Dose Dependent Reduction of ProteinuriaCompletedNCT00768638Phase 4
• The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant PatientsCompletedNCT00767897
• Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4CompletedNCT00764816Not applicable
• Tryptophan Metabolism in Kidney DiseaseCompletedNCT00758537
• The Use of Low Molecular Weight Heparin in HemodiafiltrationCompletedNCT00756145Phase 4
• Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney DiseaseCompletedNCT00755690Not applicable
• A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on HemodialysisCompletedNCT00750295Phase 1/2
• The Role of Vitamin D in Immune Function in Patients With Chronic Kidney Disease (CKD) Stages 3 and 4.CompletedNCT00749736Phase 4
• Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent ActivityCompletedNCT00744445Phase 2
• Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney DiseaseCompletedNCT00742716Phase 2
• Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk AssessmentCompletedNCT00741585Phase 4
• Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment ProceduresCompletedNCT00735059Not applicable
• Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement TherapyCompletedNCT00728364
• Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell ExchangeCompletedNCT00725517Phase 4
• Endothelin Receptor Antagonism in Proteinuric NephropathyCompletedNCT00722215Phase 1
• Aliskiren and Muscle Sympathetic Nerve ActivityStatus unknownNCT00719316Phase 4
• A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.CompletedNCT00717821Phase 3
• Study of Tacrolimus Immunosuppressive Therapy After Kidney TransplantationCompletedNCT00717379Phase 4
• Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal FailureCompletedNCT00716573Phase 4
• Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on HemodialysisCompletedNCT00704678Phase 2
• Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on HemodialysisCompletedNCT00704483Phase 2
• Circadian Rhythm of Erythropoietin And Melatonin in Renal DiseaseCompletedNCT00698360
• Inulin and Protein Fermentation in Hemodialysis PatientsCompletedNCT00695513Phase 1/2
• Automated Clinical Reminders in the Care of Chronic Kidney Disease PatientsCompletedNCT00688285Not applicable
• Queen's University Investigation of Calcification in Chronic Kidney DiseaseCompletedNCT00687661Phase 3
• Redox State in the Course of Chronic Renal Insufficiency and Hemodialysis: Implications in MorbimortalityCompletedNCT00684034Not applicable
• An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On DialysisCompletedNCT00681941Phase 3
• A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) PatientsCompletedNCT00679991Phase 1/2
• Intensive Dietary Education to Lower Serum Phosphorus in Patients With Chronic Kidney DiseaseCompletedNCT00656279Not applicable
• Clinical Feature and Outcome of Angiographic Coronary Artery Disease in Chronic Kidney Disease PatientsStatus unknownNCT00651521
• Paricalcitol Injection Phase II TrialCompletedNCT00646932Phase 2
• Chronic Kidney Disease Prevention of An-Lo District, KeelungCompletedNCT00644046Phase 4
• A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on DialysisCompletedNCT00642967Phase 3
• A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney DiseaseCompletedNCT00641589Phase 1
• Effect of Protein-Restricted Diet on Nitrogen Balance and Residual Renal Function in Peritoneal Dialysis (PD) PatientsCompletedNCT00633646Not applicable
• Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal InsufficiencyTerminatedNCT00630708Not applicable
• Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and AnemiaWithdrawnNCT00609544Phase 2
• Identification of Cardiovascular Risk Factors Linked to Renal Failure ProgressionCompletedNCT00608998
• Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney DiseaseCompletedNCT00600951
• Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney DiseaseCompletedNCT00600834
• Impact of CAMP in an Ambulatory Renal ClinicStatus unknownNCT00599365Not applicable
• Comparison of Dialysis Therapies on Cognitive FunctionCompletedNCT00597103
• A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney FunctionCompletedNCT00596518Phase 1
• Effect of Parenteral Iron Therapy on Inflammatory Response and Oxidative Stress Chronic HemodialysisCompletedNCT00583973
• Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney DiseaseTerminatedNCT00581269Phase 2
• A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney TransplantTerminatedNCT00576602Phase 4
• More Frequent Dialysis (>3 Treatments Per Week)CompletedNCT00575497Not applicable
• Improved Delivery of Cardiovascular Care Through Outreach FacilitationCompletedNCT00574808Phase 1
• Optimalization of Nephroprotection Using N-AcetylcysteineCompletedNCT00572663Not applicable
• Optimalization of Nephroprotection Using Atorvastatin (Sortis)CompletedNCT00572312Not applicable
• Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney DiseaseCompletedNCT00566670
• Multiple Intervention and AUdit in Renal Diseases to Optimize CareCompletedNCT00566033Phase 4
• A Study of Cytokine and Inflammatory Markers in Patients With Chronic Renal FailureCompletedNCT00565994
• Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3Status unknownNCT00565396Not applicable
• Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis PatientsCompletedNCT00561093Phase 3
• Nutrient Levels Alter Transplant OutcomeCompletedNCT00560014Not applicable
• Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic NephropathyCompletedNCT00556465Phase 2/3
• Immune Response to Influenza VaccinationCompletedNCT00551837
• A Study of Iron Oligosaccharide in Chronic Kidney Disease PatientsCompletedNCT00536666Phase 3
• Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With HyperphosphatemiaCompletedNCT00530114Phase 2
• Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone SystemCompletedNCT00528385Not applicable
• Erythropoietin Resistance in Anemia of Chronic Kidney DiseaseCompletedNCT00526747
• Effects of Oral Cholecalciferol (Vitamin D3) on Bone Health, Neuromuscular Function, and Quality of Life in Adults With Chronic Kidney DiseaseCompletedNCT00511225Not applicable

← Renal Insufficiency, Chronic overview